Get started

VTGN

Vistagen (VTGN): Long-term Game-changer* This is not financial advice. This is my non-expert opinion. * Vistagen ( NASDAQ:VTGN ) is a clinical stage biopharmaceutical company with long-term potential. I believe it's technology is similarly game-changing the way I believe NanoFlu for Novavax is (www.novavax.com) ( ). It could have positive outcomes for the world. I hope that their tech comes to fruition. Their pipeline includes Neuroactive nasal sprays that don't involve benzodiazepine and its associated side effects. I hope they succeed because it could change the way patients with anxiety or depression-related disorders are treated. Vistagen: www.vistagen.com Pipeline: www.vistagen.com PH94B Neuroactive Nasal Spray is their most advanced candidate, which is currently in Stage 3 clinical trials. I encourage anyone who wants to do their own research. This animated demonstration was very informative for me www.youtube.com Keep an eye out for this company.
NASDAQ:VTGNLong
by traderman001
VTGN - DAILY CHARTHi, today we are going to talk about VistaGen Therapeutics Inc and its current landscape. VistaGen Therapeutics Inc despite the high volatility of this penny stock it could be hiding a gold mine as the company has received Fast Track designation by the FDA for the development of the company's PH94B neuroactive nasal spray for on-demand treatment of social anxiety disorder. The clinical-stage biopharmaceutical company has been developing this new generation of medicines for central nervous system diseases and disorders that don't have their needs by the currently products on the market, with this FDA designation PH94B that it's preparing to enter on its phase 3 development, has the potential of being next VistaGen gem, since could meet the need of 15 million adults that in the U.S (6.8% of the population), suffers of social anxiety disorder*, a context that made VistaGen Therapeutics worth to follow closely. Thank you for reading and leave your comments if you like. To have access to our exclusive contents, join the Traders Heaven today! Link Below. *ADAA - Anxiety and Depression Association of America Disclaimer: All content of Golden Dragon has only educational and informational purposes, and never should be used or take it as financial advice.
NASDAQ:VTGN
by Igor-Silva
VTGN - Perfect Retracement - Bulls in controlVistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of new generation medicines to treat diseases and disorders of the central nervous system. Its portfolio focuses on three clinical-stage product; neuropathic pain (NP), levodopa-induced dyskinesia (LID), social anxiety disorder (SAD) and suicidal ideation (SI). Its product include AV-101 product and PH10 neuroactive nasal spray.The company was founded by H. Ralph Snodgrass and Gordon Keller on May 26, 1998 and is headquartered in South San Francisco, CA. SHORTS 1.79M 09/13/19 P/E Current -1.08 P/E Ratio (with extraordinary items) -1.49 Average Recommendation: OVERWEIGHT Average Target Price: 2.35
NASDAQ:VTGNLong
by DEXWireNews